S. J. H. Van Deventer focuses on Internal medicine, Tumor necrosis factor alpha, Immunology, Cytokine and Endocrinology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Recombinant DNA. His biological study spans a wide range of topics, including Sepsis, Coagulation, Escherichia coli, Fibrinolysis and Necrosis.
His Immunology research includes themes of Inflammatory bowel disease, Coagulopathy and Tuberculosis. His studies deal with areas such as Whole blood and Immune system as well as Cytokine. The concepts of his Endocrinology study are interwoven with issues in CD14, Thrombin and In vivo.
S. J. H. Van Deventer spends much of his time researching Immunology, Internal medicine, Tumor necrosis factor alpha, Cytokine and Crohn's disease. S. J. H. Van Deventer interconnects Disease and Inflammatory bowel disease in the investigation of issues within Immunology. His Internal medicine study incorporates themes from Gastroenterology and Endocrinology.
His Tumor necrosis factor alpha research includes themes of Pathogenesis, Neutrophil degranulation, Necrosis, Antibody and Pharmacology. His Cytokine research incorporates themes from Proinflammatory cytokine and Lymph. S. J. H. Van Deventer has included themes like Surgery, Infliximab and Immunotherapy in his Crohn's disease study.
His primary areas of investigation include Immunology, Internal medicine, Crohn's disease, Disease and Gastroenterology. In most of his Immunology studies, his work intersects topics such as Inflammatory bowel disease. His biological study spans a wide range of topics, including Endocrinology and Surgery.
His Crohn's disease research incorporates elements of Infliximab, Peripheral blood and Microbiology. The Gastroenterology study combines topics in areas such as Dysplasia, Ulcerative colitis, Differential diagnosis, Biopsy and Colonoscopy. As part of the same scientific family, he usually focuses on Tumor necrosis factor alpha, concentrating on Sepsis and intersecting with Interleukin 6, Disseminated intravascular coagulation, Fibrinolysis and Anticoagulant.
His primary areas of study are Internal medicine, Gastroenterology, Immunology, Ulcerative colitis and Surgery. His Internal medicine study frequently links to other fields, such as Endocrinology. S. J. H. Van Deventer has researched Gastroenterology in several fields, including Differential diagnosis, Biopsy, Radiology, Endoscopy and Colonoscopy.
His Immunology study integrates concerns from other disciplines, such as Intestinal mucosa and Programmed cell death. His Ulcerative colitis research is multidisciplinary, incorporating perspectives in Laparoscopic surgery, Enema and Peripheral blood mononuclear cell. His study in Cytokine is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Proinflammatory cytokine, Colitis and Inflammatory bowel disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Infliximab for the treatment of fistulas in patients with Crohn's disease.
D.H. Present;P.J. Rutgeerts;S.R. Targan;S.B. Hanauer.
The New England Journal of Medicine (1999)
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
H. M. Van Dullemen;S. J. H. Van Deventer;D. W. Hommes;H. A. Bijl.
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
S. J. H. Van Deventer;H. R. Buller;J. W. Ten Cate;L. A. Aarden.
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
Geert D'Haens;S Van Deventer;R Van Hogezand;D Chalmers.
Activation of coagulation after administration of tumor necrosis factor to normal subjects.
T. van der Poll;H. R. Büller;H. ten Cate;C. H. Wortel.
The New England Journal of Medicine (1990)
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.
T ten Hove;C van Montfrans;M P Peppelenbosch;S J H van Deventer.
Tumour necrosis factor and Crohn's disease.
S.J.H. van Deventer.
Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.
S.J.H. van Deventer;C.O. Elson;R.N. Fedorak.
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets
D W Hommes;M P Peppelenbosch;S J H van Deventer.
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
M Levi;H ten Cate;K A Bauer;T van der Poll.
Journal of Clinical Investigation (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: